Cargando…

Editorial Comment to Prostate carcinoma with neuroendocrine differentiation successfully treated by early detection with imaging examination

Detalles Bibliográficos
Autores principales:	Inamoto, Teruo, Azuma, Haruhito
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Editorial Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609174/ https://www.ncbi.nlm.nih.gov/pubmed/33163927 http://dx.doi.org/10.1002/iju5.12235

Ejemplares similares

Editorial Comment to Case of renal mucinous tubular and spindle cell carcinoma with high nuclear grade
por: Inamoto, Teruo, et al.
Publicado: (2019)

Prostate carcinoma with neuroendocrine differentiation successfully treated by early detection with imaging examination
por: Kobayashi, Momoko, et al.
Publicado: (2020)

Editorial Comment to Utility of whole‐body diffusion‐weighted magnetic resonance imaging in the management of treatment‐related neuroendocrine prostate cancer
por: Yoshida, Soichiro, et al.
Publicado: (2020)

CRISPR Screen Contributes to Novel Target Discovery in Prostate Cancer
por: Tsujino, Takuya, et al.
Publicado: (2021)

Editorial Comment to Granulomatous prostatitis with high suspicion of prostatic adenocarcinoma on radiological imaging
por: Sekito, Takanori, et al.
Publicado: (2021)

Immunotherapy of Genitourinary Malignancies
por: Inamoto, Teruo, et al.
Publicado: (2012)

Rapid Increase of the Serum PSA Level in Response to High-Intensity Focused Ultrasound Therapy may be a Potential Indicator of Biochemical Recurrence of Low- and Intermediate-Risk Prostate Cancer
por: Inamoto, Teruo, et al.
Publicado: (2011)

Editorial Comment: Translational research in urology: nutricion and prostate
por: Favorito, Luciano A.
Publicado: (2021)

Editorial Comment to Advanced adrenocortical carcinoma successfully treated with gemcitabine plus capecitabine as second‐line chemotherapy
por: Kandori, Shuya
Publicado: (2020)

Editorial Comment to Prominent response to platinum‐based chemotherapy in a patient with BRCA2 mutant‐neuroendocrine prostate cancer and MDM2 amplification
por: Matsumoto, Takashi, et al.
Publicado: (2021)

Editorial comment: Renal denervation
por: Schmieder, Roland E., et al.
Publicado: (2021)

Editorial Comment: Overall survival prediction in metastatic castration-resistant prostate cancer treated with radium-223
por: dos Reis, Rodolfo Borges, et al.
Publicado: (2020)

Editorial Comment from Dr Kato to A case of metastatic treatment‐emergent small cell/neuroendocrine prostate cancer with BRCA2 mutation by liver biopsy
por: Kato, Manabu
Publicado: (2022)

Editorial Comment
por: Madbouly, Khaled
Publicado: (2011)

EDITORIAL COMMENT
por: Mladenov, Dimitar
Publicado: (2013)

EDITORIAL COMMENT
por: Gibas, Artur
Publicado: (2013)

EDITORIAL COMMENT
por: Salagierski, Maciej
Publicado: (2013)

EDITORIAL COMMENT
por: Tiu, Albert, et al.
Publicado: (2013)

EDITORIAL COMMENT
por: Poletajew, Sławomir, et al.
Publicado: (2013)

EDITORIAL COMMENT
por: Oszukowska, Elżbieta
Publicado: (2013)

EDITORIAL COMMENT
por: Matuszewski, Marcin
Publicado: (2013)

EDITORIAL COMMENT
por: Świniarski, Piotr Paweł
Publicado: (2013)

EDITORIAL COMMENT
por: Apoznański, Wojciech
Publicado: (2013)

Editorial Comment
por: Goel, Apul
Publicado: (2023)

Editorial Comment to Primary basal cell carcinoma of the prostate with concurrent adenocarcinoma
por: Funahashi, Yasuhito
Publicado: (2020)

Editorial Comment to Microscopic pulmonary tumor embolism from adenocarcinoma of the prostate
por: Iguchi, Taro, et al.
Publicado: (2020)

Editorial Comment to Undifferentiated pleomorphic sarcoma of the prostate in a young man
por: Ochi, Atsuhiko
Publicado: (2020)

Editorial Comment to Nonmetastatic castration‐resistant prostate cancer treated with salvage focal brachytherapy after external beam radiotherapy
por: Hirayama, Yukiyoshi, et al.
Publicado: (2021)

Editorial Comment: Vasectomy re-reversal: effectiveness and parameters associated with its success
por: Vieiralves, Rodrigo R.
Publicado: (2021)

Editorial Comment to Systemic treatment for coexisting mucinous urethral adenocarcinoma and prostate adenocarcinoma
por: Watari, Shogo, et al.
Publicado: (2020)

Editorial Comment to Case of atypical femoral fractures that mimicked the typical imaging findings of prostate cancer‐induced bone metastasis
por: Rajeev, TP
Publicado: (2019)

Editorial Comment: Does successful urethral calibration rule out significant female urethral stenosis? confronting the confounder- an outcome analysis of successfully treated female urethral strictures
por: Cavalcanti, André G.
Publicado: (2021)

Editorial comments: treatment of motor fluctuations in Parkinson’s disease
por: Korczyn, Amos D.
Publicado: (2011)

Editorial Comment from Dr Sekino and Dr Hinata to A case of metastatic treatment emergent small cell/neuroendocrine prostate cancer with BRCA2 mutation diagnosed by liver biopsy
por: Sekino, Yohei, et al.
Publicado: (2022)

Comment on Informing relatives of their genetic risk: an examination of the Belgian context
por: de Paor, Aisling
Publicado: (2022)

Editorial Comment to Prostate squamous cell carcinoma developing 11 years after external radiotherapy for prostate adenocarcinoma
por: Uehara, Sho
Publicado: (2020)

Editorial Comments: Is multiple sclerosis a neurodegenerative or inflammatory disease?
por: Korczyn, Amos D.
Publicado: (2013)

Comment to “Recurrent Glioblastoma Treated with Recombinant Poliovirus”
por: Wang, Peng, et al.
Publicado: (2018)

Editorial Comment to Considerations for the use of gonadotropin‐releasing hormone agonists and antagonists in patients with prostate cancer
por: Kawahara, Takashi
Publicado: (2020)

Editorial Comment: Comparison of pain levels in fusion prostate biopsy and standard TRUS-Guided biopsy
por: Diniz, Andre Luiz Lima
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_54nc8arujdked3gl14p9s730rl